如果您對這些純文本內容做了任何改變,很快就會看到。

研究成果 1994 2019

篩選
文章
2005
23 引文 (Scopus)

Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer

Margolin, K. A., Doroshow, J. H., Frankel, P., Chow, W., Leong, L. A., Lim, D., McNamara, M., Morgan, R. J., Shibata, S., Somlo, G., Twardowski, P., Yen, Y., Kogut, N., Schriber, J., Alvarnas, J. & Stalter, S., 十一月 1 2005, 於 : Biology of Blood and Marrow Transplantation. 11, 11, p. 903-911 9 p.

研究成果: 雜誌貢獻文章

Germ Cell and Embryonal Neoplasms
Paclitaxel
Stem Cells
Drug Therapy
Peripheral Blood Stem Cell Transplantation
11 引文 (Scopus)

Ribozyme cleavage leads to decreased expression of fibroblast growth factor receptor 3 in human multiple myeloma cells, which is associated with apoptosis and downregulation of vascular endothelial growth factor

Qian, S., Somlo, G., Zhou, B., Zhu, L., Mi, S., Mo, X., Cheung, E. M., Qiu, W., Lin, R. J., Rossi, J., Holtz, M., Chu, P. & Yen, Y., 四月 7 2005, 於 : Oligonucleotides. 15, 1, p. 1-11 11 p.

研究成果: 雜誌貢獻文章

Receptor, Fibroblast Growth Factor, Type 3
Catalytic RNA
Multiple Myeloma
Vascular Endothelial Growth Factor A
Down-Regulation
25 引文 (Scopus)

The ribonucleotide reductase subunit M2B subcellular localization and functional importance for DNA replication in physiological growth of KB cells

Liu, X., Zhou, B., Xue, L., Shih, J., Tye, K., Qi, C. & Yen, Y., 十一月 1 2005, 於 : Biochemical Pharmacology. 70, 9, p. 1288-1297 10 p.

研究成果: 雜誌貢獻文章

KB Cells
Ribonucleotide Reductases
DNA Replication
DNA
Phase Transition
76 引文 (Scopus)

The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells

Wang, T., Tamae, D., LeBon, T., Shively, J. E., Yen, Y. & Li, J. J., 十一月 15 2005, 於 : Cancer Research. 65, 22, p. 10338-10346 9 p.

研究成果: 雜誌貢獻文章

Peroxiredoxins
Ionizing Radiation
Radiation
Breast Neoplasms
Reactive Oxygen Species
2006
106 引文 (Scopus)

A ferrous-triapine complex mediates formation of reactive oxygen species that inactivate human ribonucleotide reductase

Shao, J., Zhou, B., Di Bilio, A. J., Zhu, L., Wang, T., Qi, C., Shih, J. & Yen, Y., 三月 1 2006, 於 : Molecular Cancer Therapeutics. 5, 3, p. 586-592 7 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Reactive Oxygen Species
Catalase
Superoxide Dismutase
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
24 引文 (Scopus)

Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment

Juhasz, A., Vassilakos, A., Chew, H. K., Gandara, D. & Yen, Y., 五月 1 2006, 於 : Oncology Reports. 15, 5, p. 1299-1304 6 p.

研究成果: 雜誌貢獻文章

Real-Time Polymerase Chain Reaction
Messenger RNA
Leukocytes
Pharmaceutical Preparations
Down-Regulation
14 引文 (Scopus)
Ribonucleotide Reductases
Holoenzymes
Assays
Diphosphates
In Vitro Techniques
5 引文 (Scopus)

Enzymatic property analysis of p53R2 subunit of human ribonucleotide reductase

Yen, Y., Chu, B., Yen, C., Shih, J. & Zhou, B., 九月 4 2006, 於 : Advances in Enzyme Regulation. 46, 1, p. 235-247 13 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Iron
Cytidine Diphosphate
Deferoxamine
Hydroxyurea
24 引文 (Scopus)

Esophageal cancer: Clinical Practice Guidelines in oncology™

Ajani, J., Bekaii-Saab, T., D'Amico, T. A., Fuchs, C., Gibson, M. K., Goldberg, M., Hayman, J. A., Ilson, D. H., Javle, M., Kelley, S., Kurtz, R. C., Locker, G. Y., Meropol, N. J., Minsky, B. D., Orringer, M. B., Osarogiagbon, R. U., Posey, J. A., Roth, J., Sasson, A. R., Swisher, S. G. 及其他2, Wood, D. E. & Yen, Y., 四月 2006, 於 : JNCCN Journal of the National Comprehensive Cancer Network. 4, 4, p. 328-347 20 p.

研究成果: 雜誌貢獻文章

Esophageal Neoplasms
Practice Guidelines
Carcinoma
Active Immunotherapy
Hiatal Hernia
2 引文 (Scopus)

Fibroblast growth factor Receptor 3 up-regulates vascular endothelial growth factor expression in L6 cells

Zhu, L., Yen, Y., Shao, J., Qi, C. H., Yen, C., Luo, J. & Zhou, B., 五月 1 2006, 於 : International Journal of Pharmacology. 2, 3, p. 324-330 7 p.

研究成果: 雜誌貢獻文章

Receptor, Fibroblast Growth Factor, Type 3
Vascular Endothelial Growth Factor A
Up-Regulation
Multiple Myeloma
Cell Proliferation
24 引文 (Scopus)

Gastric cancer: Clinical Practice Guidelines in oncology™

Ajani, J., Bekaii-Saab, T., D'Amico, T. A., Fuchs, C., Gibson, M. K., Goldberg, M., Hayman, J. A., Ilson, D. H., Javle, M., Kelley, S., Kurtz, R. C., Locker, G. Y., Meropol, N. J., Minsky, B. D., Orringer, M. B., Osarogiagbon, R. U., Posey, J. A., Roth, J., Sasson, A. R., Swisher, S. G. 及其他2, Wood, D. E. & Yen, Y., 四月 2006, 於 : JNCCN Journal of the National Comprehensive Cancer Network. 4, 4, p. 350-366 17 p.

研究成果: 雜誌貢獻文章

Practice Guidelines
Stomach Neoplasms
Stomach
Histology
Carcinoma

MAb against the small subunit of human ribonucleotide reductase (hRRM2)

Yen, Y., 十月 2006, 於 : Hybridoma. 25, 5, p. 313 1 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
45 引文 (Scopus)

Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells

Liu, X., Zhou, B., Xue, L., Shih, J., Tye, K., Lin, W., Qi, C., Chu, P., Un, F., Wen, W. & Yen, Y., 十一月 1 2006, 於 : Clinical Cancer Research. 12, 21, p. 6337-6344 8 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Neoplasm Metastasis
Neoplasms
Transfection
Colon
10 引文 (Scopus)

Modulating ICBP90 to suppress human ribonucleotide reductase M2 induction restores sensitivity to hydroxyurea cytotoxicity

Un, F., Qi, C., Prosser, M., Wang, N., Zhou, B., Bronner, C. & Yen, Y., 七月 1 2006, 於 : Anticancer Research. 26, 4 B, p. 2761-2767 7 p.

研究成果: 雜誌貢獻文章

Hydroxyurea
Ribonucleotide Reductases
Small Interfering RNA
DNA Damage
S Phase Cell Cycle Checkpoints
8 引文 (Scopus)

Production of a monoclonal antibody against the hRRM2 subunit of ribonucleotide reductase and immunohistochemistry study of human cancer tissues

Zhou, B., Phan, V., Liu, X., Juhasz, A., Chu, P. G. & Yen, Y., 一月 1 2006, 於 : Hybridoma. 25, 5, p. 264-270 7 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Immunohistochemistry
Monoclonal Antibodies
Neoplasms
Paraffin
209 引文 (Scopus)

Ribonucleotide reductase inhibitors and future drug design

Shao, J., Zhou, B., Chu, B. & Yen, Y., 2006, 於 : Current Cancer Drug Targets. 6, 5, p. 409-431 23 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Drug Design
Clinical Trials
gemcitabine
Neoplasms
31 引文 (Scopus)

Structurally dependent redox property of ribonucleotide reductase subunit p53R2

Xue, L., Zhou, B., Liu, X., Wang, T., Shih, J., Qi, C., Heung, Y. & Yen, Y., 二月 15 2006, 於 : Cancer Research. 66, 4, p. 1900-1905 6 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Oxidation-Reduction
Reactive Oxygen Species
Mitochondrial Membrane Potential
Oxidative Stress
5 引文 (Scopus)

SUMOylation plays a role in gemcitabine- and bortezomib-induced cytotoxicity in human oropharyngeal carcinoma KB gemcitabine-resistant clone

Chung, V., Zhou, B., Liu, X., Zhu, L., Boo, L. M., Nguyen, H. V., Ann, D. K., Song, J., Chen, Y. & Yen, Y., 三月 1 2006, 於 : Molecular Cancer Therapeutics. 5, 3, p. 533-540 8 p.

研究成果: 雜誌貢獻文章

gemcitabine
Sumoylation
Clone Cells
Carcinoma
KB Cells
2007
6 引文 (Scopus)

An increase of cytochrome C oxidase mediated disruption of gemcitabine incorporation into DNA in a resistant KB clone

Liu, X., Zhou, B., Mi, S., Xue, L., Shih, J., Lee, J., Chau, J., Un, F. & Yen, Y., 六月 15 2007, 於 : Biochemical Pharmacology. 73, 12, p. 1927-1938 12 p.

研究成果: 雜誌貢獻文章

gemcitabine
Gems
Electron Transport Complex IV
Cytochromes
Sodium Azide
25 引文 (Scopus)

Annexin-I as a potential target for green tea extract induced actin remodeling

Xiao, G. S., Jin, Y. S., Lu, Q. Y., Zhang, Z. F., Belldegrun, A., Figlin, R., Pantuck, A., Yen, Y., Li, F. & Rao, J. Y., 一月 1 2007, 於 : International Journal of Cancer. 120, 1, p. 111-120 10 p.

研究成果: 雜誌貢獻文章

Annexin A1
Tea
Actins
Microfilament Proteins
Urinary Bladder Neoplasms
3 引文 (Scopus)

A phase I study of oxaliplatin in combination with gemcitabine: Correlation of clinical outcome with gene expression

Shibata, S., Chow, W., Frankel, P., Juhasz, A., Leong, L., Lim, D., Margolin, K., Morgan, R., Newman, E., Somlo, G., Yen, Y., Synold, T., Gandara, D., Lenz, H. J. & Doroshow, J., 三月 1 2007, 於 : Cancer Chemotherapy and Pharmacology. 59, 4, p. 549-557 9 p.

研究成果: 雜誌貢獻文章

oxaliplatin
gemcitabine
Gene expression
Gene Expression
Maximum Tolerated Dose
12 引文 (Scopus)

A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45β expression in hepatocellular carcinoma cells

Jiang, C., Zhou, B., Fan, K., Heung, E., Xue, L., Liu, X., Kirschbaum, M. & Yen, Y., 十一月 1 2007, 於 : Anticancer Research. 27, 6 B, p. 3783-3789 7 p.

研究成果: 雜誌貢獻文章

Depsipeptides
Azacitidine
DNA Damage
Hepatocellular Carcinoma
Gene Expression
5 引文 (Scopus)

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: A California Cancer Consortium Trial

Morgan, R. J., Synold, T. W., Gandara, D., Muggia, F., Scudder, S., Reed, E., Margolin, K., Raschko, J., Leong, L., Shibata, S., Tetef, M., Vasilev, S., McGonigle, K., Longmate, J., Yen, Y., Chow, W., Somlo, G., Carroll, M. & Doroshow, J. H., 三月 1 2007, 於 : International Journal of Gynecological Cancer. 17, 2, p. 373-378 6 p.

研究成果: 雜誌貢獻文章

Carboplatin
Interferon-alpha
Ovarian Neoplasms
Cyclosporine
Area Under Curve
24 引文 (Scopus)

Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity

Morgan, R. J., Synold, T. W., Xi, B., Lim, D., Shibata, S., Margolin, K., Schwarz, R. E., Leong, L., Somlo, G., Twardowski, P., Yen, Y., Chow, W., Tetef, M., Lin, P., Paz, B., Koczywas, M., Wagman, L., Chu, D., Frankel, P., Stalter, S. 及其他1, Doroshow, J. H., 二月 15 2007, 於 : Clinical Cancer Research. 13, 4, p. 1232-1237 6 p.

研究成果: 雜誌貢獻文章

gemcitabine
Peritoneal Cavity
Area Under Curve
Neoplasms
Therapeutics
111 引文 (Scopus)

Potent siRNA inhibitors of ribonucleotide reductase subunit RRM2 reduce cell proliferation In vitro and In vivo

Heidel, J. D., Liu, J. Y. C., Yen, Y., Zhou, B., Heale, B. S. E., Rossi, J. J., Bartlett, D. W. & Davis, M. E., 四月 1 2007, 於 : Clinical Cancer Research. 13, 7, p. 2207-2215 9 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Small Interfering RNA
Cell Proliferation
Luciferases
Cultured Cells
36 引文 (Scopus)

Ribonucleotide reductase small subunit p53R2 facilitates p21 induction of G1 arrest under UV irradiation

Xue, L., Zhou, B., Liu, X., Heung, Y., Chau, J., Chu, E., Li, S., Jiang, C., Un, F. & Yen, Y., 一月 1 2007, 於 : Cancer Research. 67, 1, p. 16-21 6 p.

研究成果: 雜誌貢獻文章

Cyclin-Dependent Kinase 2
Ribonucleotide Reductases
DNA Repair
DNA Damage
Amino Acids
44 引文 (Scopus)

Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer

Liu, X., Zhou, B., Xue, L., Yen, F., Chu, P., Un, F. & Yen, Y., 一月 1 2007, 於 : Clinical Colorectal Cancer. 6, 5, p. 374-381 8 p.

研究成果: 雜誌貢獻文章

Colonic Neoplasms
Biomarkers
Neoplasm Metastasis
Ribonucleotide Reductases
Diphosphates
119 引文 (Scopus)

Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression

Li, X., Lee, Y. K., Jeng, J. C., Yen, Y., Schultz, D. C., Shih, H. M. & Ann, D. K., 十二月 14 2007, 於 : Journal of Biological Chemistry. 282, 50, p. 36177-36189 13 p.

研究成果: 雜誌貢獻文章

Sumoylation
Phosphorylation
Serine
Switches
Proteins
287 引文 (Scopus)

Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor

Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D. & Huang, W., 二月 1 2007, 於 : Cancer Research. 67, 3, p. 863-867 5 p.

研究成果: 雜誌貢獻文章

Bile Acids and Salts
Liver
Neoplasms
Homeostasis
Liver Cell Adenoma
17 引文 (Scopus)

The induction of growth arrest DNA damage-inducible gene 45 β in human hepatoma cell lines by S-adenosylmethionine

Qiu, W., Zhou, B., Chu, P. G., Luh, F. & Yen, Y., 一月 1 2007, 於 : American Journal of Pathology. 171, 1, p. 287-296 10 p.

研究成果: 雜誌貢獻文章

S-Adenosylmethionine
DNA Damage
Hepatocellular Carcinoma
Binding Sites
Cell Line
2 引文 (Scopus)

Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice

Lin, H. H., Xiong, Y., Ho, Y. S., Zhou, B., Nguyen, H. V., Deng, H., Lee, R., Yen, Y., Borok, Z. & Ann, D. K., 二月 1 2007, 於 : European Journal of Oral Sciences. 115, 1, p. 30-39 10 p.

研究成果: 雜誌貢獻文章

Salivary Glands
varespladib methyl
Transgenic Mice
Transcription Factors
Aquaporin 5
2008
33 引文 (Scopus)
Carcinoembryonic Antigen
Cell Adhesion Molecules
Protein Isoforms
Breast Neoplasms
Alternative Splicing
51 引文 (Scopus)

ATM-mediated serine 72 phosphorylation stabilizes ribonucleotide reductase small subunit p53R2 protein against MDM2 to DNA damage

Chang, L., Zhou, B., Hu, S., Guo, R., Liu, X., Jones, S. N. & Yen, Y., 十一月 25 2008, 於 : Proceedings of the National Academy of Sciences of the United States of America. 105, 47, p. 18519-18524 6 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Ataxia Telangiectasia
Protein Subunits
Serine
DNA Damage
77 引文 (Scopus)

Autoantibodies as potential biomarkers for breast cancer

Zhong, L., Ge, K., Zu, J. C., Zhao, L. H., Shen, W. K., Wang, J. F., Zhang, X. G., Gao, X., Hu, W., Yen, Y. & Kernstine, K. H., 六月 7 2008, 於 : Breast Cancer Research. 10, 3, R40.

研究成果: 雜誌貢獻文章

Autoantibodies
Biomarkers
Bacteriophages
Breast Neoplasms
Proteins
105 引文 (Scopus)

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry

Coston, W. M. P., Loera, S., Lau, S. K., Ishizawa, S., Jiang, Z., Wu, C. L., Yen, Y., Weiss, L. M. & Chu, P. G., 三月 1 2008, 於 : American Journal of Surgical Pathology. 32, 3, p. 433-444 12 p.

研究成果: 雜誌貢獻文章

Glypicans
Hepatocellular Carcinoma
Focal Nodular Hyperplasia
Immunohistochemistry
Liver
45 引文 (Scopus)

Human DNA polymerase η activity and translocation is regulated by phosphorylation

Chen, Y. W., Cleaver, J. E., Hatahet, Z., Honkanen, R. E., Chang, J. Y., Yen, Y. & Chou, K. M., 十月 28 2008, 於 : Proceedings of the National Academy of Sciences of the United States of America. 105, 43, p. 16578-16583 6 p.

研究成果: 雜誌貢獻文章

gemcitabine
DNA-Directed DNA Polymerase
Phosphorylation
Cisplatin
Protein Interaction Domains and Motifs
8 引文 (Scopus)

Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy

Xiao, G. G., Zhou, B. S., Somlo, G., Portnow, J., Juhasz, A., Un, F., Chew, H., Gandara, D. & Yen, Y., 一月 1 2008, 於 : Cancer Genomics and Proteomics. 5, 3-4, p. 151-160 10 p.

研究成果: 雜誌貢獻文章

Biomarkers
Ribonucleotide Reductases
Breast Neoplasms
Ionization
Mass spectrometry
2 引文 (Scopus)

Modern staging and utility of PET imaging in esophageal cancer management

Chang, K. Y., Chang, J. Y., Chao, J. & Yen, Y., 一月 1 2008, 於 : JNCCN Journal of the National Comprehensive Cancer Network. 6, 9, p. 862-869 8 p.

研究成果: 雜誌貢獻文章

Esophageal Neoplasms
Neoadjuvant Therapy
Fluorodeoxyglucose F18
Positron-Emission Tomography
Neoplasms
46 引文 (Scopus)

NCCN task force report: mTOR inhibition in solid tumors

Figlin, R. A., Brown, E., Armstrong, A. J., Akerley, W., Benson, A. B., Burstein, H. J., Ettinger, D. S., Febbo, P. G., Fury, M. G., Hudes, G. R., Kies, M. S., Kwak, E. L., Morgan, R. J., Mortimer, J., Reckamp, K., Venook, A. P., Worden, F. & Yen, Y., 十月 9 2008, 於 : JNCCN Journal of the National Comprehensive Cancer Network. 6, SUPPL. 5

研究成果: 雜誌貢獻文章

Advisory Committees
Sirolimus
Neoplasms
TOR Serine-Threonine Kinases
Head and Neck Neoplasms
30 引文 (Scopus)

Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer a California cancer consortium trial

Yen, Y., Lim, D. W., Chung, V., Morgan, R. J., Leong, L. A., Shibata, S. I., Wagman, S. D., Marx, H., Chu, P. G., Longmate, J. A., Lenz, H. J., Ramanathan, R. K., Belani, C. P. & Gandara, D. R., 八月 1 2008, 於 : American Journal of Clinical Oncology: Cancer Clinical Trials. 31, 4, p. 317-322 6 p.

研究成果: 雜誌貢獻文章

oxaliplatin
Liver Neoplasms
Hepatocellular Carcinoma
Neoplasms
Survival
30 引文 (Scopus)

Protein phosphatase PP4 is overexpressed in human breast and lung tumors

Wang, B., Zhao, A., Sun, L., Zhong, X., Zhong, J., Wang, H., Cai, M., Li, J., Xu, Y., Liao, J., Sang, J., Chowdhury, D., Pfeifer, G. P., Yen, Y. & Xu, X., 九月 2008, 於 : Cell Research. 18, 9, p. 974-977 4 p.

研究成果: 雜誌貢獻文章

Phosphoprotein Phosphatases
Enzyme Inhibitors
Tumor Cell Line
Lung Neoplasms
Immunohistochemistry
5 引文 (Scopus)

Study the property of double-ended fluoroalkyl poly(ethylene glycol) hydrogel as a depot for hydrophobic drug delivery using electron paramagnetic resonance technique and cell proliferation assay

Liu, X., Mao, Y., Mathias, E. V., Ma, C., Franco, O., Ba, Y., Kornfield, J. A., Wang, T., Xue, L., Zhou, B. S. & Yen, Y., 三月 1 2008, 於 : Journal of Sol-Gel Science and Technology. 45, 3, p. 269-278 10 p.

研究成果: 雜誌貢獻文章

Hydrogel
Cell proliferation
Drug delivery
Hydrogels
Polyethylene glycols
43 引文 (Scopus)

Symptoms concern and quality of life in hepatobiliary cancers

Sun, V., Ferrell, B., Juarez, G., Wagman, L. D., Yen, Y. & Chung, V., 五月 2008, 於 : Oncology Nursing Forum. 35, 3, p. 357 1 p.

研究成果: 雜誌貢獻文章

Quality of Life
Neoplasms
Liver Neoplasms
Pancreatic Neoplasms
Hepatocellular Carcinoma
27 引文 (Scopus)

Synthesis and Ribonucleotide reductase inhibitory activity of thiosemicarbazones

Krishnan, K., Prathiba, K., Jayaprakash, V., Basu, A., Mishra, N., Zhou, B., Hu, S. & Yen, Y., 十二月 1 2008, 於 : Bioorganic and Medicinal Chemistry Letters. 18, 23, p. 6248-6250 3 p.

研究成果: 雜誌貢獻文章

Thiosemicarbazones
Ribonucleotide Reductases
Hydroxyurea
Cytidine Diphosphate
Holoenzymes
90 引文 (Scopus)

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph - acute lymphoblastic leukemia cells

Scuto, A., Kirschbaum, M., Kowolik, C., Kretzner, L., Juhasz, A., Atadja, P., Pullarkat, V., Bhatia, R., Forman, S., Yen, Y. & Jove, R., 五月 15 2008, 於 : Blood. 111, 10, p. 5093-5100 8 p.

研究成果: 雜誌貢獻文章

Histone Deacetylase Inhibitors
Precursor Cell Lymphoblastic Leukemia-Lymphoma
DNA Damage
Genes
Apoptosis
2009
28 引文 (Scopus)

2.6 Å X-ray crystal structure of human p53R2, a p53-inducible ribonucleotide reductase

Smith, P., Zhou, B., Ho, N., Yuan, Y. C., Su, L., Tsai, S. C. & Yen, Y., 十一月 24 2009, 於 : Biochemistry. 48, 46, p. 11134-11141 8 p.

研究成果: 雜誌貢獻文章

Ribonucleotide Reductases
Iron
Crystal structure
X-Rays
X rays
2 引文 (Scopus)

Amyand's hernia in elderly patients: Diagnostic, anesthetic, and perioperative considerations

Yang, W., Tao, Z., Chen, H., Li, Q., Chu, P. G., Yen, Y. & Qiu, W., 十二月 1 2009, 於 : Journal of Investigative Surgery. 22, 6, p. 426-429 4 p.

研究成果: 雜誌貢獻文章

Hernia
Anesthetics
Groin
Inguinal Hernia
Appendectomy
12 引文 (Scopus)

A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: A study of the PMH phase II consortium

Leighl, N. B., Laurie, S. A., Chen, X. E., Ellis, P., Shepherd, F. A., Knox, J. J., Goss, G., Burkes, R. L., Pond, G. R., Dick, C., Yen, Y., Zwiebel, J. A. & Moore, M. J., 一月 1 2009, 於 : Journal of Thoracic Oncology. 4, 9, p. 1163-1169 7 p.

研究成果: 雜誌貢獻文章

docetaxel
Non-Small Cell Lung Carcinoma
Intravenous Infusions
Therapeutics
Febrile Neutropenia
175 引文 (Scopus)

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H. J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., MacK, P. C., Lurje, G., Gandour-Edwards, R., Dancey, J. & Gandara, D. R., 九月 1 2009, 於 : Cancer Chemotherapy and Pharmacology. 64, 4, p. 777-783 7 p.

研究成果: 雜誌貢獻文章

Biliary Tract
Liver Neoplasms
Disease-Free Survival
Neoplasms
Skin
4 引文 (Scopus)

Bortezomib therapeutic effect is associated with expression of FGFR3 in multiple myeloma cells

Guan, M., Zhu, L., Somlo, G., Hughes, A., Zhou, B. & Yen, Y., 一月 1 2009, 於 : Anticancer Research. 29, 1, p. 1-9 9 p.

研究成果: 雜誌貢獻文章

Receptor, Fibroblast Growth Factor, Type 3
Therapeutic Uses
Multiple Myeloma
Bortezomib
Mutation